BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36245024)

  • 1. Myeloid-derived Suppressor Cells Activate Liver Natural Killer Cells in a Murine Model in Uveal Melanoma.
    Wang YY; Li SY; Chen SQ; Wang LL; Han ZQ
    Curr Med Sci; 2022 Oct; 42(5):1071-1078. PubMed ID: 36245024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.
    Sadegh L; Chen PW; Brown JR; Han Z; Niederkorn JY
    Int J Cancer; 2015 Sep; 137(5):1085-94. PubMed ID: 25683463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells.
    Nausch N; Galani IE; Schlecker E; Cerwenka A
    Blood; 2008 Nov; 112(10):4080-9. PubMed ID: 18753637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models.
    Shime H; Kojima A; Maruyama A; Saito Y; Oshiumi H; Matsumoto M; Seya T
    J Innate Immun; 2014; 6(3):293-305. PubMed ID: 24192491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.
    Jones NM; Yang H; Zhang Q; Morales-Tirado VM; Grossniklaus HE
    BMC Cancer; 2019 May; 19(1):484. PubMed ID: 31117965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity.
    Mao Y; Sarhan D; Steven A; Seliger B; Kiessling R; Lundqvist A
    Clin Cancer Res; 2014 Aug; 20(15):4096-106. PubMed ID: 24907113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated NK cells reprogram MDSCs via NKG2D-NKG2DL and IFN-γ to modulate antitumor T-cell response after cryo-thermal therapy.
    Peng P; Lou Y; Wang S; Wang J; Zhang Z; Du P; Zheng J; Liu P; Xu LX
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36521929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.
    Fujimura T; Ring S; Umansky V; Mahnke K; Enk AH
    J Invest Dermatol; 2012 Apr; 132(4):1239-46. PubMed ID: 22189788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells.
    Ren J; Zeng W; Tian F; Zhang S; Wu F; Qin X; Zhang Y; Lin Y
    Am J Reprod Immunol; 2019 Apr; 81(4):e13099. PubMed ID: 30737988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b
    Takahashi R; Amano H; Ito Y; Eshima K; Satoh T; Iwamura M; Nakamura M; Kitasato H; Uematsu S; Raouf J; Jakobsson PJ; Akira S; Majima M
    Biomed Pharmacother; 2020 Jan; 121():109581. PubMed ID: 31715374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
    Ma D; Luyten GP; Luider TM; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural killer cell activity.
    Neelam S; Mellon J; Wilkerson A; Niederkorn JY
    Melanoma Res; 2019 Aug; 29(4):401-412. PubMed ID: 30932943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ-Induced Myeloid-Derived Suppressor Cells Aggravate Kidney Ischemia-Reperfusion Injury by Regulating Innate Immune Cells.
    Ji J; Zhuang Y; Lin Z; Jiang Y; Wang W; Zhang X
    Nephron; 2022; 146(1):99-109. PubMed ID: 34569551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver.
    Cripps JG; Wang J; Maria A; Blumenthal I; Gorham JD
    Hepatology; 2010 Oct; 52(4):1350-9. PubMed ID: 20803559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells.
    Yang H; Dithmar S; Grossniklaus HE
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2056-64. PubMed ID: 15223777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.
    Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ
    J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.